A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure

Blood Purification

Volumn 28, Issue 3, 2009, Pages 151-158

  Karvellas, Constantine J ^a   Bagshaw, Sean M ^a,b   McDermid, Robert C ^a   Stollery, Daniel E ^a   Bain, Vincent G ^a   Gibney, R T Noel ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acetaminophen; Acute liver failure; Fulminant hepatic failure; Multi organ failure; Single pass albumin dialysis

Indexed keywords

ALBUMIN; PARACETAMOL;

ADULT; APACHE; ARTICLE; BACTEREMIA; BLEEDING; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; DRUG OVERDOSE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; FEMALE; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 67649834471     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227280     Document Type: Article

References (41)

1. Fagan E, Wannan G: Reducing paracetamol overdoses. BMJ 1996; 313: 1417-1418.
2. Bernal W: Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23: 227-237.
3. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiodt FV, Ostapowicz G, Shakil AO, Lee WM: Acetaminophen- induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-1372.
4. Myers RP, Li B, Fong A, Shaheen AA, Quan H: Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health 2007; 7: 143.
5. O'Grady JG, Alexander GJ, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445. (Pubitemid 19192181)
6. Corbally M, Rela M, Heaton N, Tan K: Standard orthotopic operation, retransplantation and piggybacking; in Williams R, Portmann B, Tan K (eds): The Practice of Liver Transplantation. Edinburgh, Churchill Livingstone, 1995, pp 135-142.
7. Karvellas CJ, Gibney N, Kutsogiannis D, Wendon J, Bain VG: Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure. Crit Care 2007; 11: 215.
8. Sen S, Williams R, Jalan R: Emerging indications for albumin dialysis. Am J Gastroenterol 2005; 100: 468-475.
9. Nalesso F, Brendolan A, Crepaldi C, Cruz D, de Cal M, Bellomo R, Ronco C: Albumin dialysis and plasma filtration adsorption dialysis system. Contrib Nephrol 2007; 156: 411-418.
10. Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Gibney RT: Acetaminophen-induced acute liver failure treated with singlepass albumin dialysis: report of a case. Int J Artif Organs 2008; 31: 450-455.
11. Patzer J: Principles of bound solute dialysis. Ther Apher Dial 2006; 10: 118-124.
12. Patzer JF 2nd, Safta SA, Miller RH: Slow continuous ultrafiltration with bound solute dialysis. ASAIO J 2006; 52: 47-58.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: Apache II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
14. Polson J: Assessment of prognosis in acute liver failure. Semin Liver Dis 2008; 28: 218-225.
15. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG: MELD is superior to King's College and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007; 13: 822-828.
16. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT: Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
17. Whitcomb DC, Block GD: Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845-1850.
18. Bernal W, Wendon J, Rela M, Heaton N, Williams R: Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27: 1050-1055. (Pubitemid 28160491)
19. Brandsaeter B, Höckerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, Olausson M, Broome U, Schmidt L, Foss A, Bjøro K: Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation - 12 years experience in the Nordic countries. Liver Transpl 2002; 8: 1055-1062.
20. Santoro A, Mancini E, Ferramosca E, Faenza S: Liver support systems. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 396-404.
21. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J: Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36: 949-958.
22. Schmidt LE, Wang LP, Hansen BA, Larsen FS: Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003; 9: 290-297.
23. El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R: First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004; 50: 332-337.
24. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D: Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 2003; 39: 984-990.
25. Skwarek A, Grodzicki M, Nyckowski P, Kotulski M, Zieniewicz K, Michalowicz B, Patkowski W, Grzelak I, Paczkowska A, Giercuszkiewicz D, Sanko-Resmer J, Paczek L, Krawczyk M: The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc 2006; 38: 209-211.
26. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F: Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10: R108.
27. Rifai K, Ernst T, Kretschmer U, Hafer C, Haller H, Manns MP, Fliser D: The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005; 23: 298-302.
28. Chawla LS, Georgescu F, Abell B, Seneff MG, Kimmel PL: Modification of continuous venovenous hemodiafiltration with singlepass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 2005; 45: e51-e56.
29. Camus C, Lavoue S, Gacouin A, Le Tulzo Y, Lorho R, Boudjema K, Jacquelinet C, Thomas R: Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006; 32: 1817-1825.
30. Isoniemi H, Koivusalo AM, Repo H, Ilonen I, Höckerstedt K: The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transplant Proc 2005; 37: 1088-1090.
31. Tsai MH, Chen YC, Wu CS, Ho YP, Fang JT, Lien JM, Yang C, Chu YY, Liu NJ, Lin CH, Chiu CT, Chen PC: Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure. Int J Clin Pract 2005; 59: 1289-1294.
32. Lee KH, Lee MK, Sutedja DS, Lim SG: Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int 2005; 25: 973-977.
33. Lai WK, Haydon G, Mutimer D, Murphy N: The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. Intensive Care Med 2005; 31: 1544-1549.
34. Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P: In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39: 1408-1414.
35. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M: Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31: 1080-1085.
36. Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA: Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol 2008; 23: 1013-1016.
37. Rahman E, Al Suwaida AK, Askar A: Single pass albumin dialysis in hepatorenal syndrome. Saudi J Kidney Dis Transpl 2008; 19: 479-484.
38. Doria C, Mandala L, Smith JD, Caruana G, Scott VL, Gruttadauria S, Magnone M, Marino IR: Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004; 18: 365-371.
39. Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006; 10:R24.
40. Hessel FP: Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Cost Eff Resour Alloc 2006; 4: 16.
41. Wong F: Drug insight: the role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 43-51.